Comfort Systems USA has reversed last week's sell-off sharply, closing at $1,981.95 — up 3.9% on the week — with short sellers pulling back meaningfully as the July 23 earnings date draws closer.
The most notable data shift this week is in positioning. Short interest fell 14.3% over the past seven days, dropping from a recent peak near 941,000 shares to roughly 794,000 — now at 2.3% of the free float. That reverses the steady accumulation flagged in the prior note, which had seen shorts drift higher through mid-June. The retreat is not panic-driven; the borrow market remains utterly benign, with cost-to-borrow at 0.41% and availability at an extraordinary 5,180% — meaning the lending pool dwarfs current demand by a factor of more than fifty. The ORTEX short score has eased to 31.2 from 32.9 a week ago, consistent with a de-risking of short books rather than any squeeze dynamic. Options tell a similar story of calm: the put/call ratio is 1.36, precisely in line with its 20-day average and carrying a z-score near zero. There is no sign of elevated hedging demand or directional conviction in the options market.
The Street is broadly constructive, with recent analyst activity skewing positive. UBS raised its target to $2,125 from $1,992 on June 8 while maintaining its Buy rating — the second consecutive target lift from that desk, which had already moved from $1,680 to $1,992 in late April. Oppenheimer initiated with an Outperform and a $2,200 target on May 28. The consensus mean price target of $2,048 implies a modest premium to the current price. Factor scores reinforce the fundamental confidence: the 90-day EPS momentum rank at the 92nd percentile and an 86th-percentile EPS surprise rank point to a company that consistently delivers above expectations. The bear case — articulated around economic sensitivity in commercial construction — is structurally unchanged, but the 30-day PE expansion of roughly 1.5 turns to 40.7x and EV/EBITDA near 28.8x show investors are paying up for the execution track record.
Insider selling remains the one persistent counterweight. The CFO sold close to $10m worth of shares in early May, and the independent chairman sold another $13m on June 24. Net insider selling across the past 90 days totals roughly $68.6m. The transactions carry low significance scores and are spread across multiple officers, which points more toward routine diversification at elevated prices than a coordinated exit — but the cadence is worth noting at a stock trading near $2,000. The prior week's sharp divergence from peers, which saw MTZ, ECG, and MYRG each gain 6-12% while FIX stalled, has largely resolved: FIX's 3.9% weekly gain now brings it back in line with PWR (+2.5%) and IESC (+3.4%), though MTZ added another 6.6% this week and MYRG gained 6.9%, suggesting FIX is still recovering lost ground relative to the most momentum-driven names in the group.
What to watch next: the July 23 Q2 print will test whether FIX can sustain the mid-to-high 20s revenue growth that management guided toward, and whether the recent modular data-center pipeline and the new West Coast electrical acquisition are showing up in margins — a set of questions that the options and short markets are currently treating with more calm than drama.
See the live data behind this article on ORTEX.
Open FIX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
